NCT03186781View on ClinicalTrials.gov

Influenza HA Ferritin Vaccine, Alone or in Prime-Boost Regimens With an Influenza DNA Vaccine in Healthy Adults

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 25, 2017

Primary Completion Date

September 3, 2019

Study Completion Date

September 3, 2019

Conditions

Influenza

Interventions

BIOLOGICAL

VRC-FLUNPF081-00-VP (HA-F A/Sing)

VRC-FLUNPF081-00-VP (HA-F A/Sing) is an investigational influenza HA ferritin vaccine.

BIOLOGICAL

VRC-FLUDNA082-00-VP (DNA A/Sing)

VRC-FLUDNA082-00-VP (DNA A/Sing) is an investigational influenza plasmid DNA vaccine.

Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT03186781 - Influenza HA Ferritin Vaccine, Alone or in Prime-Boost Regimens With an Influenza DNA Vaccine in Healthy Adults | Biotech Hunter | Biotech Hunter